Secondary treatment failure in cervical dystonia after treatment with inco- and abobotulinumtoxinA

Angela Jochim; Florian Castrop; Burkard Jochim; Bernhard Haslinger

doi:10.1016/j.parkreldis.2015.03.016

Secondary treatment failure in cervical dystonia after treatment with inco- and abobotulinumtoxinA

Angela Jochim, Florian Castrop, Burkard Jochim, Bernhard Haslinger

Default

Technical University of Munich

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	663-664
Number of pages	2
Journal	Parkinsonism and Related Disorders
Volume	21
Issue number	6
DOIs	https://doi.org/10.1016/j.parkreldis.2015.03.016
State	Published - 1 Jun 2015

Keywords

Cervical dystonia
IncobotulinumtoxinA
Secondary treatment failure

Access to Document

10.1016/j.parkreldis.2015.03.016

Cite this

@article{7386abebc2a2418fbc47af67107272da,

title = "Secondary treatment failure in cervical dystonia after treatment with inco- and abobotulinumtoxinA",

keywords = "Cervical dystonia, IncobotulinumtoxinA, Secondary treatment failure",

author = "Angela Jochim and Florian Castrop and Burkard Jochim and Bernhard Haslinger",

note = "Funding Information: A. Jochim has received travel grants from Ipsen, Ipsen, Allergan, St. Jude Medical and AbbVie and speaker honoraria from Allergan. F. Castrop has received travel grants from AbbVie, Ipsen, Allergan and Merz Pharmaceuticals. B. Jochim has no financial disclosures. B. Haslinger receives research support from Ipsen and DFG, has served on a scientific advisory board for Merz Pharmaceuticals, has received speaker honoraria from Allergan, Desitin, GlaxoSmithKline, Ipsen and Novartis and has received travel grants from Biogen Idec, Ipsen, Medtronic and Merz Pharmaceuticals.",

year = "2015",

month = jun,

day = "1",

doi = "10.1016/j.parkreldis.2015.03.016",

language = "English",

volume = "21",

pages = "663--664",

journal = "Parkinsonism and Related Disorders",

issn = "1353-8020",

publisher = "Elsevier Ltd.",

number = "6",

}

TY - JOUR

T1 - Secondary treatment failure in cervical dystonia after treatment with inco- and abobotulinumtoxinA

AU - Jochim, Angela

AU - Castrop, Florian

AU - Jochim, Burkard

AU - Haslinger, Bernhard

N1 - Funding Information: A. Jochim has received travel grants from Ipsen, Ipsen, Allergan, St. Jude Medical and AbbVie and speaker honoraria from Allergan. F. Castrop has received travel grants from AbbVie, Ipsen, Allergan and Merz Pharmaceuticals. B. Jochim has no financial disclosures. B. Haslinger receives research support from Ipsen and DFG, has served on a scientific advisory board for Merz Pharmaceuticals, has received speaker honoraria from Allergan, Desitin, GlaxoSmithKline, Ipsen and Novartis and has received travel grants from Biogen Idec, Ipsen, Medtronic and Merz Pharmaceuticals.

PY - 2015/6/1

Y1 - 2015/6/1

KW - Cervical dystonia

KW - IncobotulinumtoxinA

KW - Secondary treatment failure

UR - http://www.scopus.com/inward/record.url?scp=84929517500&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2015.03.016

DO - 10.1016/j.parkreldis.2015.03.016

M3 - Letter

C2 - 25819807

AN - SCOPUS:84929517500

SN - 1353-8020

VL - 21

SP - 663

EP - 664

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

IS - 6

ER -

Secondary treatment failure in cervical dystonia after treatment with inco- and abobotulinumtoxinA

Keywords

Access to Document

Other files and links

Cite this